Swiss pharmaceutical company mulling investment in IranMonday, Apr 27, 2015(SHADA: TEHRAN) – Head of the association of Iran-Swiss mutual investment said Monday that following a visit to Iran of Swiss economic delegation, well-known Swiss pharmaceutical company Novartis is mulling investment in Iran.
Speaking exclusively to IRNA, Hossein Salimi said that Novartis has examined capacities of Iranian market and decided to make investment in Iran.
Novartis is a multinational company based in Basel, Switzerland and is one of the biggest pharmaceutical corporations.
Referring to the visit to Tehran by the Swiss delegation, Salimi said that given the economic slowdown across the Europe, a lot of the European countries are mulling investment in Iran.
Salimi said that during their stay in Tehran, the Swiss economic delegation met with high-ranking Iranian officials and visited a number of companies and industrial units of the country.